Novo Nordisk (NYSE:NVO) Q4 2025 Earnings call February 04, 2026 07:00 AM ET Company ParticipantsDave Moore - EVPKarsten Munk Knudsen - CFOLudovic Helfgott - EVPMartin Holst Lange - EVP and Chief Scientific OfficerMaziar Doustdar - CEOMichael Novod - Head of Investor RelationsConference Call ParticipantsCarsten Lønborg Madsen - AnalystHarry Sephton - AnalystJames Quigley - AnalystMike Nedelcovic - AnalystPeter Verdult - AnalystRichard Vosser - AnalystSimon Baker - AnalystThibault Boutherin - AnalystOperatorG ...

Novo Nordisk (NYSE:NVO) Q4 2025 Earnings call February 04, 2026 07:00 AM ET Speaker6Good day, and thank you for standing by. Welcome to the Q4 2025 Novo Nordisk Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question during the session, you will need to press star one and one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question ...